Search - tctmd.com

Displaying 81 - 100 of 141

Sort: Relevancy | Date

Presentation Cell Therapy 2013

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

Presenter: Amit N. Patel

January 22, 2013

Presentation Cell Therapy 2013

NOGA-Guided CD133+ Cells for CMI

Presenter: Wojciech Wojakowski

January 22, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

Presenter: Eduardo Marb?n

January 22, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

Biologic Therapy For Claudication FIM Strategy

Presenter: Todd J. Brinton

January 22, 2013

Presentation Cell Therapy 2013

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

Presentation Cell Therapy 2013

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

Adipose derived cells or chronic myocardial ischemia

Presenter: Francisco Fdez-Avil?s

January 22, 2013

Presentation Cell Therapy 2013

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Presenter: Emerson C.Perin

January 22, 2013

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

Presentation Cell Therapy 2012

Selling Cells: The Ethics of Marketing (Unproven) Stem Cell Therapies

Presenter: Timothy Caulfield

January 26, 2012

Presentation Cell Therapy 2012

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Presenter: Stephen G. Ellis

January 26, 2012

Presentation Cell Therapy 2012

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

Presenter: Les Miller

January 26, 2012

Presentation Cell Therapy 2012

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

Presenter: Matthew Feshbach

January 26, 2012

Presentation Cell Therapy 2012

NIH Clinical Trial Research Network

Presenter: Jay H. Traverse

January 26, 2012

Advertisement

REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy

NOGA-Guided CD133+ Cells for CMI

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

IMPACT Clinical Trial Program: Findings and Strategic Update

IK 5001 - A Novel Approach to Myocardial Remodeling

EXCELLENT Trial Design

Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR

BMAC for CLI: Status of a Phase 3 Trial

Biologic Therapy For Claudication FIM Strategy

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Adipose derived cells or chronic myocardial ischemia

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

Selling Cells: The Ethics of Marketing (Unproven) Stem Cell Therapies

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

NIH Clinical Trial Research Network

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content